Correlation Between Grupo Televisa and Tarsus Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Grupo Televisa and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Grupo Televisa and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Grupo Televisa SAB and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Grupo Televisa and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Grupo Televisa with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Grupo Televisa and Tarsus Pharmaceuticals.

Diversification Opportunities for Grupo Televisa and Tarsus Pharmaceuticals

-0.42

Correlation Coefficient

Grupo Televisa  Tarsus Pharmaceuticals

Very good diversification

The 3 months correlation between Grupo and Tarsus is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Grupo Televisa SAB and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Grupo Televisa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Grupo Televisa SAB are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Grupo Televisa i.e., Grupo Televisa and Tarsus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Grupo Televisa and Tarsus Pharmaceuticals

Allowing for the 90-day total investment horizon Grupo Televisa SAB is expected to under-perform the Tarsus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Grupo Televisa SAB is 1.13 times less risky than Tarsus Pharmaceuticals. The stock trades about 0.0 of its potential returns per unit of risk. The Tarsus Pharmaceuticals is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  1,750  in Tarsus Pharmaceuticals on September 14, 2024 and sell it today you would earn a total of  3,505  from holding Tarsus Pharmaceuticals or generate 200.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Grupo Televisa SAB  vs.  Tarsus Pharmaceuticals

Grupo Televisa SAB

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Grupo Televisa SAB are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Grupo Televisa is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Tarsus Pharmaceuticals

Risk-Adjusted Performance

22 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Grupo Televisa and Tarsus Pharmaceuticals

The main advantage of trading using opposite Grupo Televisa and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Grupo Televisa position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.

The idea behind Grupo Televisa SAB and Tarsus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.